Guru Ownership Trend
Guru Analysis for Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.54 M.
Top institutional holders include Renaissance Technologies (RenTech) and Louis Moore Bacon.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $746,462.75 net outflow during the quarter.
Recent activity highlights Louis Moore Bacon who increased their stake by 288.2%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 32.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Dyne Therapeutics, Inc. (DYN)
Major holders include Renaissance Technologies (RenTech) ($8.01 M), Louis Moore Bacon ($6.79 M), Ken Fisher ($6.63 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.05 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $746,462.75, with 1 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited DYN. The total reported sell value was $5.79 M.
Yes, 0 managers opened new positions in DYN, and 1 increased their existing holdings. The total reported buy value was $5.04 M.